Holdings
Foresite Capital Management VI, LLC
As of Jun 30, 2026, Foresite Capital Management VI, LLC reported 22 positions worth US$617M. Largest: Cg Oncology, Inc., Alumis Inc. and Seaport Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cg Oncology, Inc. | 2.37M | US$168M | +148K | Jun 30, 2026 |
| Alumis Inc. | 4.25M | US$120M | no change | Jun 30, 2026 |
| Seaport Therapeutics, Inc. | 1.78M | US$38.7M | new | Jun 30, 2026 |
| Denali Therapeutics Inc. | 1.4M | US$35.9M | +187K | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 880K | US$32.7M | +564K | Jun 30, 2026 |
| Agios Pharmaceuticals, Inc. | 785K | US$29.1M | +260K | Jun 30, 2026 |
| Corvus Pharmaceuticals, Inc. | 1.83M | US$27.4M | no change | Jun 30, 2026 |
| Parabilis Medicines, Inc. | 999K | US$27.3M | new | Jun 30, 2026 |
| Jade Biosciences, Inc. | 887K | US$19.7M | +567K | Jun 30, 2026 |
| Hinge Health, Inc. | 220K | US$18.3M | no change | Jun 30, 2026 |